Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts. - Moreland,L.W.; Pratt,P.W.; Bucy,R.P. (Arthritis Rheum, 1994)